At close: 4:00:02 PM EST
After hours: 4:01:26 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.36M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DOGAN MEESHANTHINI Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
| DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
| DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
| DOGAN TIMUR Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
| DOGAN TIMUR Chief Technology Officer | Purchase at price 0.29 per share. | Direct | 20,000 | Sep 6, 2024 |
| PHILIBERT ROBERT Officer and Director | Purchase at price 0.28 - 0.29 per share. | Indirect | 9,763 | Sep 6, 2024 |
| LEVY ODED Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
| INTRATER JAMES Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
| BURTON PAUL FREDERICK Director | Conversion of Exercise of derivative security at price 1.42 per share. | Direct | 12,500 | Mar 28, 2024 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 2.18 per share. | Direct | 1,999 | Jan 31, 2024 |
| SIM BRANDON Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
| LEVY ODED Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
| LEVY ODED Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 16,499 | Dec 29, 2023 |
| INTRATER JAMES Director | Conversion of Exercise of derivative security at price 2.49 per share. | Direct | 12,500 | Dec 29, 2023 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 0.30 per share. | Direct | 2,000 | Oct 31, 2023 |
| SIM BRANDON Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
| LEVY ODED Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
| LEVY ODED Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 0.34 - 1.21 per share. | Direct | 18,500 | Sep 29, 2023 |
| INTRATER JAMES Director | Conversion of Exercise of derivative security at price 0.34 per share. | Direct | 12,500 | Sep 29, 2023 |
| DOGAN MEESHANTHINI Chief Executive Officer | Purchase at price 0.54 - 0.56 per share. | Indirect | 9,964 | Aug 31, 2023 |
| DOGAN TIMUR Chief Technology Officer | Purchase at price 0.54 - 0.56 per share. | Direct | 9,964 | Aug 31, 2023 |
| PHILIBERT ROBERT Officer, Director and Beneficial Owner | Purchase at price 0.57 - 0.60 per share. | Indirect | 20,395 | Aug 28, 2023 |
| SIM BRANDON Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 25,000 | Jun 30, 2023 |
| LAU STANLEY K Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 34,999 | Jun 30, 2023 |
Related Tickers
PXMD PaxMedica, Inc.
0.0650
-1.22%
ZVSA ZyVersa Therapeutics, Inc.
1.4700
+24.58%
CMND Clearmind Medicine Inc.
1.5300
+6.25%
QNRX Quoin Pharmaceuticals, Ltd.
0.6215
-0.26%
BDRX Biodexa Pharmaceuticals Plc
4.5400
+4.37%
NKGN NKGen Biotech, Inc.
0.4890
-14.59%
VRPX Virpax Pharmaceuticals, Inc.
0.3690
+0.93%
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%
SPRC SciSparc Ltd.
0.8149
+1.03%
TVGN Tevogen Bio Holdings Inc.
1.4500
+12.40%